Compare URGN & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | URGN | NRDS |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 922.1M | 1.0B |
| IPO Year | 2016 | 2021 |
| Metric | URGN | NRDS |
|---|---|---|
| Price | $19.24 | $11.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $29.29 | $15.67 |
| AVG Volume (30 Days) | 697.0K | ★ 1.2M |
| Earning Date | 06-10-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.42 |
| EPS | N/A | ★ 0.64 |
| Revenue | $1,128,000.00 | ★ $836,600,000.00 |
| Revenue This Year | $119.37 | $7.55 |
| Revenue Next Year | $64.79 | $8.31 |
| P/E Ratio | ★ N/A | $17.34 |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $3.42 | $7.55 |
| 52 Week High | $30.00 | $16.24 |
| Indicator | URGN | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 54.00 |
| Support Level | $18.65 | $10.25 |
| Resistance Level | $20.44 | $11.35 |
| Average True Range (ATR) | 1.59 | 0.66 |
| MACD | -0.13 | 0.28 |
| Stochastic Oscillator | 32.02 | 94.78 |
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.